Search strategies.

Database	Search strategy
PubMed	(“Breast Neoplasm”[tiab] OR (Neoplasm[tiab] AND Breast[tiab]) OR “Breast Tumor*”[tiab] OR (Tumor*[tiab] AND Breast[tiab]) OR (Neoplasm*[tiab] AND Breast[tiab]) OR “Breast Cancer”[tiab] OR (Cancer[tiab] AND Breast[tiab]) OR “Mammary Cancer*”[tiab] OR (Cancer*[tiab] AND Mammary[tiab]) OR “Malignant Neoplasm of Breast”[tiab] OR “Breast Malignant Neoplasm*”[tiab] OR “Malignant Tumor of Breast”[tiab] OR “Breast Malignant Tumor*”[tiab] OR “Cancer of Breast”[tiab] OR “Cancer of the Breast”[tiab] OR (“Mammary Carcinoma”[tiab] AND Human[tiab]) OR (Carcinoma*[tiab] AND “Human Mammary”[tiab]) OR “Human Mammary Carcinoma*”[tiab] OR (“Mammary Carcinoma*”[tiab] AND Human[tiab]) OR (“Mammary Neoplasm*”[tiab] AND Human[tiab]) OR “Human Mammary Neoplasm*”[tiab] OR (Neoplasm*[tiab] AND “Human Mammary”[tiab]) OR (“Mammary Neoplasm*”[tiab] AND Human[tiab]) OR “Breast Carcinoma*”[tiab] OR (Carcinoma*[tiab] AND Breast[tiab])) AND (Mammograph*[tiab] OR “Digital Mammograph*”[tiab] OR “Digital Breast Tomosynthesis”[tiab] OR (“Breast Tomosyntheses”[tiab] AND Digital[tiab]) OR (“Breast Tomosynthesis”[tiab] AND Digital[tiab]) OR “Digital Breast Tomosyntheses”[tiab] OR “3D-Mammograph*”[tiab] OR “X-ray Breast Tomosynthesis”[tiab] OR (“Breast Tomosyntheses”[tiab] AND “X-ray”[tiab]) OR (“Breast Tomosynthesis”[tiab] AND “X-ray”[tiab]) OR “X ray Breast Tomosynthesis”[tiab] OR “X-ray Breast Tomosyntheses”[tiab]) AND ((Analyses[tiab] AND “Cost-Benefit”[tiab]) OR (Analysis[tiab] AND “Cost-Benefit”[tiab]) OR “Cost-Benefit Analyses”[tiab] OR “Cost Benefit Analysis”[tiab] OR (Analyses[tiab] AND “Cost Benefit”[tiab]) OR (Analysis[tiab] AND “Cost Benefit”[tiab]) OR “Cost Benefit Analyses”[tiab] OR “Cost Effectiveness”[tiab] OR (Effectiveness[tiab] AND Cost[tiab]) OR “Cost-Benefit Data”[tiab] OR “Cost Benefit Data”[tiab] OR (Data[tiab] AND “Cost-Benefit”[tiab]) OR “Cost-Utility Analysis”[tiab] OR (Analyses[tiab] AND “Cost-Utility”[tiab]) OR (Analysis[tiab] AND “Cost-Utility”[tiab]) OR “Cost Utility Analysis”[tiab] OR “Cost-Utility Analyses”[tiab] OR “Economic Evaluation”[tiab] OR “Economic Evaluations”[tiab] OR (Evaluation[tiab] AND Economic[tiab]) OR (Evaluations[tiab] AND Economic[tiab]) OR “Marginal Analysis”[tiab] OR (Analyses[tiab] AND Marginal[tiab]) OR (Analysis[tiab] AND Marginal[tiab]) OR “Marginal Analyses”[tiab] OR “Cost Benefit”[tiab] OR “Costs and Benefits”[tiab] OR “Benefits and Costs”[tiab] OR “Cost-Effectiveness Analysis”[tiab] OR (Analysis[tiab] AND “Cost-Effectiveness”[tiab]) OR “Cost Effectiveness Analysis”[tiab])
Scopus	(TITLE-ABS-KEY(“Breast Neoplasm”) OR (TITLE-ABS-KEY(Neoplasm) AND TITLE-ABS-KEY(Breast)) OR TITLE-ABS-KEY(“Breast Tumor*”) OR (TITLE-ABS-KEY(Tumor*) AND TITLE-ABS-KEY(Breast)) OR (TITLE-ABS-KEY(Neoplasm*) AND TITLE-ABS-KEY(Breast)) OR TITLE-ABS-KEY(“Breast Cancer”) OR (TITLE-ABS-KEY(Cancer) AND TITLE-ABS-KEY(Breast)) OR TITLE-ABS-KEY(“Mammary Cancer*”) OR (TITLE-ABS-KEY(Cancer*) AND TITLE-ABS-KEY(Mammary)) OR TITLE-ABS-KEY(“Malignant Neoplasm of Breast”) OR TITLE-ABS-KEY(“Breast Malignant Neoplasm*”) OR TITLE-ABS-KEY(“Malignant Tumor of Breast”) OR TITLE-ABS-KEY(“Breast Malignant Tumor*”) OR TITLE-ABS-KEY(“Cancer of Breast”) OR TITLE-ABS-KEY(“Cancer of the Breast”) OR (TITLE-ABS-KEY(“Mammary Carcinoma”) AND TITLE-ABS-KEY(Human)) OR (TITLE-ABS-KEY(Carcinoma*) AND TITLE-ABS-KEY(“Human Mammary”)) OR TITLE-ABS-KEY(“Human Mammary Carcinoma*”) OR (TITLE-ABS-KEY(“Mammary Carcinoma*”) AND TITLE-ABS-KEY(Human)) OR (TITLE-ABS-KEY(“Mammary Neoplasm*”) AND TITLE-ABS-KEY(Human)) OR TITLE-ABS-KEY(“Human Mammary Neoplasm*”) OR (TITLE-ABS-KEY(Neoplasm*) AND TITLE-ABS-KEY(“Human Mammary”)) OR (TITLE-ABS-KEY(“Mammary Neoplasm*”) AND TITLE-ABS-KEY(Human)) OR TITLE-ABS-KEY(“Breast Carcinoma*”) OR (TITLE-ABS-KEY(Carcinoma*) AND TITLE-ABS-KEY(Breast))) AND (TITLE-ABS-KEY(Mammograph*) OR TITLE-ABS-KEY(“Digital Mammograph*”) OR TITLE-ABS-KEY(“Digital Breast Tomosynthesis”) OR (TITLE-ABS-KEY(“Breast Tomosyntheses”) AND TITLE-ABS-KEY(Digital)) OR (TITLE-ABS-KEY(“Breast Tomosynthesis”) AND TITLE-ABS-KEY(Digital)) OR TITLE-ABS-KEY(“Digital Breast Tomosyntheses”) OR TITLE-ABS-KEY(“3D-Mammograph*”) OR TITLE-ABS-KEY(“X-ray Breast Tomosynthesis”) OR (TITLE-ABS-KEY(“Breast Tomosyntheses”) AND TITLE-ABS-KEY(“X-ray”)) OR (TITLE-ABS-KEY(“Breast Tomosynthesis”) AND TITLE-ABS-KEY(“X-ray”)) OR TITLE-ABS-KEY(“X ray Breast Tomosynthesis”) OR TITLE-ABS-KEY(“X-ray Breast Tomosyntheses”)) AND ((TITLE-ABS-KEY(Analyses) AND TITLE-ABS-KEY(“Cost-Benefit”)) OR (TITLE-ABS-KEY(Analysis) AND TITLE-ABS-KEY(“Cost-Benefit”)) OR TITLE-ABS-KEY(“Cost-Benefit Analyses”) OR TITLE-ABS-KEY(“Cost Benefit Analysis”) OR (TITLE-ABS-KEY(Analyses) AND TITLE-ABS-KEY(“Cost Benefit”)) OR (TITLE-ABS-KEY(Analysis) AND TITLE-ABS-KEY(“Cost Benefit”)) OR TITLE-ABS-KEY(“Cost Benefit Analyses”) OR TITLE-ABS-KEY(“Cost Effectiveness”) OR (TITLE-ABS-KEY(Effectiveness) AND TITLE-ABS-KEY(Cost)) OR TITLE-ABS-KEY(“Cost-Benefit Data”) OR TITLE-ABS-KEY(“Cost Benefit Data”) OR (TITLE-ABS-KEY(Data) AND TITLE-ABS-KEY(“Cost-Benefit”)) OR TITLE-ABS-KEY(“Cost-Utility Analysis”) OR (TITLE-ABS-KEY(Analyses) AND TITLE-ABS-KEY(“Cost-Utility”)) OR (TITLE-ABS-KEY(Analysis) AND TITLE-ABS-KEY(“Cost-Utility”)) OR TITLE-ABS-KEY(“Cost Utility Analysis”) OR TITLE-ABS-KEY(“Cost-Utility Analyses”) OR TITLE-ABS-KEY(“Economic Evaluation”) OR TITLE-ABS-KEY(“Economic Evaluations”) OR (TITLE-ABS-KEY(Evaluation) AND TITLE-ABS-KEY(Economic)) OR (TITLE-ABS-KEY(Evaluations) AND TITLE-ABS-KEY(Economic)) OR TITLE-ABS-KEY(“Marginal Analysis”) OR (TITLE-ABS-KEY(Analyses) AND TITLE-ABS-KEY(Marginal)) OR (TITLE-ABS-KEY(Analysis) AND TITLE-ABS-KEY(Marginal)) OR TITLE-ABS-KEY(“Marginal Analyses”) OR TITLE-ABS-KEY(“Cost Benefit”) OR TITLE-ABS-KEY(“Costs and Benefits”) OR TITLE-ABS-KEY(“Benefits and Costs”) OR TITLE-ABS-KEY(“Cost-Effectiveness Analysis”) OR (TITLE-ABS-EY(Analysis) AND TITLE-ABS-KEY(“Cost-Effectiveness”)) OR TITLE-ABS-KEY(“Cost Effectiveness Analysis”)
Web of Science	(TS=(“Breast Neoplasm”) OR (TS=(Neoplasm) AND TS=(Breast)) OR TS=(“Breast Tumor*”) OR (TS=(Tumor*) AND TS=(Breast)) OR (TS=(Neoplasm*) AND TS=(Breast)) OR TS=(“Breast Cancer”) OR (TS=(Cancer) AND TS=(Breast)) OR TS=(“Mammary Cancer*”) OR (TS=(Cancer*) AND TS=(Mammary)) OR TS=(“Malignant Neoplasm of Breast”) OR TS=(“Breast Malignant Neoplasm*”) OR TS=(“Malignant Tumor of Breast”) OR TS=(“Breast Malignant Tumor*”) OR TS=(“Cancer of Breast”) OR TS=(“Cancer of the Breast”) OR (TS=(“Mammary Carcinoma”) AND TS=(Human)) OR (TS=(Carcinoma*) AND TS=(“Human Mammary”)) OR TS=(“Human Mammary Carcinoma*”) OR (TS=(“Mammary Carcinoma*”) AND TS=(Human)) OR (TS=(“Mammary Neoplasm*”) AND TS=(Human)) OR TS=(“Human Mammary Neoplasm*”) OR (TS=(Neoplasm*) AND TS=(“Human Mammary”)) OR (TS=(“Mammary Neoplasm*”) AND TS=(Human)) OR TS=(“Breast Carcinoma*”) OR (TS=(Carcinoma*) AND TS=(Breast))) AND (TS=(Mammograph*) OR TS=(“Digital Mammograph*”) OR TS=(“Digital Breast Tomosynthesis”) OR (TS=(“Breast Tomosyntheses”) AND TS=(Digital)) OR (TS=(“Breast Tomosynthesis”) AND TS=(Digital)) OR TS=(“Digital Breast Tomosyntheses”) OR TS=(“3D-Mammograph*”) OR TS=(“X-ray Breast Tomosynthesis”) OR (TS=(“Breast Tomosyntheses”) AND TS=(“X-ray”)) OR (TS=(“Breast Tomosynthesis”) AND TS=(“X-ray”)) OR TS=(“X ray Breast Tomosynthesis”) OR TS=(“X-ray Breast Tomosyntheses”)) AND ((TS=(Analyses) AND TS=(“Cost-Benefit”)) OR (TS=(Analysis) AND TS=(“Cost-Benefit”)) OR TS=(“Cost-Benefit Analyses”) OR TS=(“Cost Benefit Analysis”) OR (TS=(Analyses) AND TS=(“Cost Benefit”)) OR (TS=(Analysis) AND TS=(“Cost Benefit”)) OR TS=(“Cost Benefit Analyses”) OR TS=(“Cost Effectiveness”) OR (TS=(Effectiveness) AND TS=(Cost)) OR TS=(“Cost-Benefit Data”) OR TS=(“Cost Benefit Data”) OR (TS=(Data) AND TS=(“Cost-Benefit”)) OR TS=(“Cost-Utility Analysis”) OR (TS=(Analyses) AND TS=(“Cost-Utility”)) OR (TS=(Analysis) AND TS=(“Cost-Utility”)) OR TS=(“Cost Utility Analysis”) OR TS=(“Cost-Utility Analyses”) OR TS=(“Economic Evaluation”) OR TS=(“Economic Evaluations”) OR (TS=(Evaluation) AND TS=(Economic)) OR (TS=(Evaluations) AND TS=(Economic)) OR TS=(“Marginal Analysis”) OR (TS=(Analyses) AND TS=(Marginal)) OR (TS=(Analysis) AND TS=(Marginal)) OR TS=(“Marginal Analyses”) OR TS=(“Cost Benefit”) OR TS=(“Costs and Benefits”) OR TS=(“Benefits and Costs”) OR TS=(“Cost-Effectiveness Analysis”) OR (TS=(Analysis) AND TS=(“Cost-Effectiveness”)) OR TS=(“Cost Effectiveness Analysis”))
Proquest	TI,AB,SU(“Breast Neoplasm” OR (Neoplasm AND Breast) OR “Breast Tumor*” OR (Tumor* AND Breast) OR (Neoplasm* AND Breast) OR “Breast Cancer” OR (Cancer AND Breast) OR “Mammary Cancer*” OR (Cancer* AND Mammary) OR “Malignant Neoplasm of Breast” OR “Breast Malignant Neoplasm*” OR “Malignant Tumor of Breast” OR “Breast Malignant Tumor*” OR “Cancer of Breast” OR “Cancer of the Breast” OR (“Mammary Carcinoma” AND Human) OR (Carcinoma* AND “Human Mammary”) OR “Human Mammary Carcinoma*” OR (“Mammary Carcinoma*” AND Human) OR (“Mammary Neoplasm*” AND Human) OR “Human Mammary Neoplasm*” OR (Neoplasm* AND “Human Mammary”) OR (“Mammary Neoplasm*” AND Human) OR “Breast Carcinoma*” OR (Carcinoma* AND Breast)) AND TI,AB,SU(Mammograph* OR “Digital Mammograph*” OR “Digital Breast Tomosynthesis” OR (“Breast Tomosyntheses” AND Digital) OR (“Breast Tomosynthesis” AND Digital) OR “Digital Breast Tomosyntheses” OR “3D-Mammograph*” OR “X-ray Breast Tomosynthesis” OR (“Breast Tomosyntheses” AND “X-ray”) OR (“Breast Tomosynthesis” AND “X-ray”) OR “X ray Breast Tomosynthesis” OR “X-ray Breast Tomosyntheses”) AND TI,AB,SU((Analyses AND “Cost-Benefit”) OR (Analysis AND “Cost-Benefit”) OR “Cost-Benefit Analyses” OR “Cost Benefit Analysis” OR (Analyses AND “Cost Benefit”) OR (Analysis AND “Cost Benefit”) OR “Cost Benefit Analyses” OR “Cost Effectiveness” OR (Effectiveness AND Cost) OR “Cost-Benefit Data” OR “Cost Benefit Data” OR (Data AND “Cost-Benefit”) OR “Cost-Utility Analysis” OR (Analyses AND “Cost-Utility”) OR (Analysis AND “Cost-Utility”) OR “Cost Utility Analysis” OR “Cost-Utility Analyses” OR “Economic Evaluation” OR “Economic Evaluations” OR (Evaluation AND Economic) OR (Evaluations AND Economic) OR “Marginal Analysis” OR (Analyses AND Marginal) OR (Analysis AND Marginal) OR “Marginal Analyses” OR “Cost Benefit” OR “Costs and Benefits” OR “Benefits and Costs” OR “Cost-Effectiveness Analysis” OR (Analysis AND “Cost-Effectiveness”) OR “Cost Effectiveness Analysis”)
Cochrane library	(“Breast Neoplasm” OR (Neoplasm AND Breast) OR “Breast Tumor*” OR (Tumor* AND Breast) OR (Neoplasm* AND Breast) OR “Breast Cancer” OR (Cancer AND Breast) OR “Mammary Cancer*” OR (Cancer* AND Mammary) OR “Malignant Neoplasm of Breast” OR “Breast Malignant Neoplasm*” OR “Malignant Tumor of Breast” OR “Breast Malignant Tumor*” OR “Cancer of Breast” OR “Cancer of the Breast” OR (“Mammary Carcinoma” AND Human) OR (Carcinoma* AND “Human Mammary”) OR “Human Mammary Carcinoma*” OR (“Mammary Carcinoma*” AND Human) OR (“Mammary Neoplasm*” AND Human) OR “Human Mammary Neoplasm*” OR (Neoplasm* AND “Human Mammary”) OR (“Mammary Neoplasm*” AND Human) OR “Breast Carcinoma*” OR (Carcinoma* AND Breast)) AND (Mammograph* OR “Digital Mammograph*” OR “Digital Breast Tomosynthesis” OR (“Breast Tomosyntheses” AND Digital) OR (“Breast Tomosynthesis” AND Digital) OR “Digital Breast Tomosyntheses” OR “3D-Mammograph*” OR “X-ray Breast Tomosynthesis” OR (“Breast Tomosyntheses” AND “X-ray”) OR (“Breast Tomosynthesis” AND “X-ray”) OR “X ray Breast Tomosynthesis” OR “X-ray Breast Tomosyntheses”) AND ((Analyses AND “Cost-Benefit”) OR (Analysis AND “Cost-Benefit”) OR “Cost-Benefit Analyses” OR “Cost Benefit Analysis” OR (Analyses AND “Cost Benefit”) OR (Analysis AND “Cost Benefit”) OR “Cost Benefit Analyses” OR “Cost Effectiveness” OR (Effectiveness AND Cost) OR “Cost-Benefit Data” OR “Cost Benefit Data” OR (Data AND “Cost-Benefit”) OR “Cost-Utility Analysis” OR (Analyses AND “Cost-Utility”) OR (Analysis AND “Cost-Utility”) OR “Cost Utility Analysis” OR “Cost-Utility Analyses” OR “Economic Evaluation” OR “Economic Evaluations” OR (Evaluation AND Economic) OR (Evaluations AND Economic) OR “Marginal Analysis” OR (Analyses AND Marginal) OR (Analysis AND Marginal) OR “Marginal Analyses” OR “Cost Benefit” OR “Costs and Benefits” OR “Benefits and Costs” OR “Cost-Effectiveness Analysis” OR (Analysis AND “Cost-Effectiveness”) OR “Cost Effectiveness Analysis”)